Skip to main content
. 2017 Nov 20;18(11):2465. doi: 10.3390/ijms18112465

Table 1.

Measured values for age and prostate-specific antigen (PSA) levels in patients with different prostate pathologies.

Prostate Pathology Age (Years) PSA (ng/mL)
CT (control, n = 9) 63 (61, 68) 0.89 (0.29, 1.53)
BPH (n = 40) 70 (60, 75) 2.05 (0.52, 5.33)
ASAP (n = 10) 68 (62, 79) 7.61 (6.44, 9.39)
PCa (n = 30) 72 (67, 76) 34.01 (12.81, 116.02)

Data are shown as medians with lower and upper quartiles (in paranthesis). CT, controls; BPH, benign prostatic hyperplasia; ASAP, atypical small acinar proliferation; PCa, prostate cancer.